Pancreatic resection
ProcedureDifferent pancreatic resections
NCT Number: NCT04741152
The blinded resection avoided in case of pancreatic insulinoma
Looking for future studies?
Notify MeAll sexes
Observational
Despite of the technique and technology developement there are still a lot of troubles to verify small benign-looking pancreatic NETs. It can be especially important in case of insulinoma. The organic hyperilsulinism and severe hypoglicemia causeb by the insulin/proinsulin - producing lesion can lead to severe complications and evem death.
There are some cases of the blinded resections of the pancreas in patients with the "hidden" insulinoma when the tumor can't be revealed during the preoperative diagnostics and intraoperatively. Unfortunately, blind resection do not solve the problem of the hypoglicemia but also cause the specific pancreatic complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The blinded resection of the insulinoma
Exclusion criteria
Other tumors
Different pancreatic resections
Time frame: 2010 June - 2020 June
To improve the diagnostics of the tumor before and during the surgery. The "hidden" insulinomas haven't been diagnosed. The frozen section have to be routinely performed. The surgery haven't been finished before the morphologic confirmation of the resected lesion.
Vishnevsky Center of Surgery
Other
Blinded Resection Avoided in Case of the Pancreatic Insulinoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585032
Adenoma, Adenoma, Islet Cell
Gothenburg, Sweden
View Trial DetailsNCT07272187
Adenoma, Adenoma, Islet Cell
Herlev, Capital Region, Denmark
View Trial DetailsNCT07340437
Adenoma, Adenoma, Islet Cell
Chengdu, China
View Trial DetailsNCT00655655
Adenocarcinoma, Adenoma
Rochester, Minnesota, United States
View Trial Details